GlassScriptPhysician profile
Munish Batra
NPI 1497847875
$4,496.42
in general payments reported to CMS, 2019-2025
22 companies · $329 in 2025
The $329 reported for 2025 was less than what a typical Plastic Surgery provider received nationally (typical 2025 total: $380).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $423 · 2020: $811 · 2021: $866 · 2022: $1,083 · 2023: $451 · 2024: $535 · 2025: $329.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,315.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,314.87 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Sientra, INC. | $1,788.72 | 2020-2022 | |
| Mentor Worldwide LLC | $910.89 | 2020-2025 | Mentor Memorygel Resterilizable Gel Sizer, Mentor Cpx 2 Breast Tissue Expander, Artoura Breast Tissue Expander |
| Neuronetics, INC. | $526.69 | 2019-2021 | |
| Allergan, INC. | $311.32 | 2019-2022 | |
| Abbvie INC. | $293.25 | 2023-2025 | Botox |
| Apyx Medical Corporation | $142.95 | 2020 | |
| Kerecis Limited | $134.92 | 2022-2023 | Kerecis Omega3 Surgiclose, Kerecis Omega3 Graftguide, Kerecis Omega3 Marigen |
| Aroa Biosurgery Incorporated | $79.28 | 2022 | |
| Integra Lifesciences Corporation | $40.95 | 2019-2022 | |
| Pacira Pharmaceuticals Incorporated | $39.15 | 2025 | Exparel |
| Motiva USA, LLC | $30.61 | 2025 | |
| Smith+Nephew, INC. | $27.26 | 2021 | |
| Medtronic USA, INC. | $25.22 | 2020 | |
| Amgen INC. | $18.96 | 2020 | |
| Lilly USA, LLC | $17.77 | 2019 |
Show all 22 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Medtronic, INC. | $17.46 | 2025 | Transorb |
| Boston Scientific Corporation | $17.04 | 2023 | Wavewriter Alpha Prime 16 |
| Lundbeck LLC | $16.99 | 2022 | |
| Galderma Laboratories, L.P. | $16.20 | 2020 | |
| Arthrosurface Incorporated | $15.22 | 2019 | |
| Tela Bio, INC. | $13.51 | 2020 | |
| Endo Pharmaceuticals INC. | $12.06 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Munish Batra listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.